1. Home
  2. PRDO vs ZYME Comparison

PRDO vs ZYME Comparison

Compare PRDO & ZYME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Perdoceo Education Corporation

PRDO

Perdoceo Education Corporation

HOLD

Current Price

$32.77

Market Cap

2.2B

Sector

Real Estate

ML Signal

HOLD

Logo Zymeworks Inc.

ZYME

Zymeworks Inc.

HOLD

Current Price

$25.02

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRDO
ZYME
Founded
1994
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
1.9B
IPO Year
1997
2022

Fundamental Metrics

Financial Performance
Metric
PRDO
ZYME
Price
$32.77
$25.02
Analyst Decision
Buy
Strong Buy
Analyst Count
1
11
Target Price
$42.00
$38.90
AVG Volume (30 Days)
524.5K
537.4K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
1.75%
N/A
EPS Growth
10.50
33.33
EPS
0.85
N/A
Revenue
$581,296,000.00
$105,965,000.00
Revenue This Year
$4.28
$183.10
Revenue Next Year
$2.89
N/A
P/E Ratio
$38.96
N/A
Revenue Growth
N/A
38.87
52 Week Low
$26.66
$11.32
52 Week High
$38.50
$29.75

Technical Indicators

Market Signals
Indicator
PRDO
ZYME
Relative Strength Index (RSI) 37.25 46.98
Support Level $32.14 $24.79
Resistance Level $32.79 $27.35
Average True Range (ATR) 0.96 1.03
MACD -0.14 0.06
Stochastic Oscillator 2.31 57.62

Price Performance

Historical Comparison
PRDO
ZYME

About PRDO Perdoceo Education Corporation

Perdoceo Education Corp is an American for-profit education company that focuses on quality postsecondary education online to a diverse student population, along with campus-based and blended learning programs. The company's important segments include the American InterContinental University, the University of St. Augustine for Health Sciences, and Colorado Technical University. These universities provide undergraduate, graduate, and doctoral degree programs focusing on business, technology, management, and social services, with the majority of the students enrolled in programs offered fully online. The majority of the its revenue comes from the Colorado Technical University segment.

About ZYME Zymeworks Inc.

Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated therapeutic product candidates. Its clinical candidate, zanidatamab, is a novel HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. It is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.

Share on Social Networks: